Combined effect of cisplatin and lymphokine-activated killer cells on A549 cells of non-small cell lung cancer.

MLA

Zhukova, O. S., et al. “Combined Effect of Cisplatin and Lymphokine-Activated Killer Cells on A549 Cells of Non-Small Cell Lung Cancer.” Bulletin of Experimental Biology and Medicine, vol. 144, no. 2, Aug. 2007, pp. 231–34. EBSCOhost, https://doi.org/10.1007/s10517-007-0297-2.

APA

Zhukova, O. S., Gerasimova, G. K., Shubina, I. Z., & Kiselevskii, M. V. (2007). Combined effect of cisplatin and lymphokine-activated killer cells on A549 cells of non-small cell lung cancer. Bulletin of Experimental Biology and Medicine, 144(2), 231–234. https://doi.org/10.1007/s10517-007-0297-2

Chicago

Zhukova, O S, G K Gerasimova, I Zh Shubina, and M V Kiselevskii. 2007. “Combined Effect of Cisplatin and Lymphokine-Activated Killer Cells on A549 Cells of Non-Small Cell Lung Cancer.” Bulletin of Experimental Biology and Medicine 144 (2): 231–34. doi:10.1007/s10517-007-0297-2.